Epilepsy Ireland has been notified by the Health Products Regulatory Authority (HPRA) that further issues are expected with the supply of the Anti-Seizure medication, Rivotril (Clonazepam).
In September, manufacturing issues created a shortage of the medication and led to difficulties for many patients in having their prescriptions filled. Although supply had returned to normal in recent weeks, it now appears that further shortages are likely.
Read more about an important development regarding this Anti-Seizure medication.
Find out why this epic Cycle has been rightly recognised as part of the annual awards!
We were delighted to recently host our National Conference in the Ashling Hotel on September 24th. For the first time in two years, the in-person element of the conference returned, and it was a pleasure to welcome Epilepsy Ireland members, volunteers & supporters to our conference.
The conference was also streamed online and for those that joined us online on the morning, you’ll be all too aware that we had a few gremlins interfering with our audio output.
Read the statement we have issued for SUDEP Action Day 2022.
Epilepsy Ireland have been contacted by UCB, manufacturers of the Anti-Seizure Medication Vimpat (Lacosamide), informing us that their patent exclusivity for the medication has now expired.
This means that other pharmaceutical manufacturers can bring forward generic versions of this medication to be marketed in Ireland.
The National Centre for Pharmacoeconomics (NCPE) have updated Epilepsy Ireland that they have issued a positive recommendation regarding the potential reimbursement of the anti-seizure medication, Cenobamate.
The medication has been indicated for use in adults living with focal-onset seizures and has posted positive clinical trial results. Epilepsy Ireland made a submission to the NCPE in July supporting reimbursement of the medication.
At a time when we have experienced record demand for our services, we have also seen a 50% drop in fundraised income. We need your support this Rose Week.
The Annual General Meeting of Brainwave, The Irish Epilepsy Association (trading as Epilepsy Ireland) for the year ending 31.12.21 was held on the 29th September 2022 via zoom.
A new exhibition in the Irish Museum of Modern Art that combines a lived experience of epilepsy; cutting edge science; and music is set to be unveiled this weekend.
At the centre of this exhibition is Debbie Boss. Debbie was diagnosed with a brain tumour in 2014. Although Debbie’s surgery to remove the tumour was successful, she subsequently developed epilepsy. The condition has had a considerable impact on Debbie’s day to day life ever since.